$149.24
8.275.87%
Last update: Nov 11, 4:00 PM
Axsome Therapeutics Inc
AXSMNASDAQ
Axsome Therapeutics rose 5.9% from $140.86 to $149.24, behind the S&P 500's +11.2%. Its worst day was Jul 31 (−7.1%), and its low came Nov 5 at $129.80.
Nov 12, 2025 – Nov 11, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Axsome Therapeutics shares rose 22.8%, while the S&P 500 fell 0.7%.
+22.8%, the year's best day · S&P 500 −0.7%
Story events cover the past 12 months · Times ET
EPS of $-0.56 beat the $-0.72 estimate on $196.0M revenue (est. $193.2M).
−4.9% · S&P 500 −1.0%
EPS of $-1.26 missed the $-0.83 estimate on $191.2M revenue (est. $190.3M).
+8.3% · S&P 500 −0.4%
Axsome Therapeutics closed at its highest level of the year, 81.2% above where the year started.
+0.6% · S&P 500 +0.5%
EPS of $-0.99 missed the $-0.87 estimate on $218.4M revenue (est. $222.3M).
+3.8% · S&P 500 0.0%
EPS of $-0.25 beat the $-0.64 estimate on $259.7M revenue (est. $248.6M).
−5.8% · S&P 500 −0.5%
Where it ended: a close of $149.24 on Nov 11, 2026. Up next: Q4 2026 earnings on Feb 22, 2027 (EPS est. $0.03, revenue est. $294.6M).
Nothing in the past 12 months.
All AXSM dividend historyReplay the year: the line draws itself and stops at each of the 6 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for AXSM and SPY from Benzinga historical bars. Not investment advice.
